Pharmaron Beijing Co., Ltd.
3759.HKFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
1,596
Cost of Revenue
1,049
Gross Profit
546
Gross Margin
34.2%
Operating Income
274
Operating Margin
17.1%
Net Income
233
Net Margin
14.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
440
EBITDA Margin
27.6%
2023
12/31/2023
Revenue
1,500
Cost of Revenue
964
Gross Profit
536
Gross Margin
35.7%
Operating Income
240
Operating Margin
16.0%
Net Income
208
Net Margin
13.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
383
EBITDA Margin
25.5%
2022
12/31/2022
Revenue
1,335
Cost of Revenue
845
Gross Profit
490
Gross Margin
36.7%
Operating Income
220
Operating Margin
16.5%
Net Income
179
Net Margin
13.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
329
EBITDA Margin
24.6%
2021
12/31/2021
Revenue
968
Cost of Revenue
619
Gross Profit
348
Gross Margin
36.0%
Operating Income
249
Operating Margin
25.7%
Net Income
216
Net Margin
22.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
324
EBITDA Margin
33.5%
2020
12/31/2020
Revenue
667
Cost of Revenue
417
Gross Profit
250
Gross Margin
37.5%
Operating Income
172
Operating Margin
25.8%
Net Income
152
Net Margin
22.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
223
EBITDA Margin
33.5%